AIHC Capital Management Ltd

CIK

2103725

Location

CENTRAL, K3

Portfolio Value

Small $119,668,108

Diversification

Highly concentrated

Filing Date

Global Rank

#5,312 / 8,605 ▲ 429 · as of Mar 2026

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+384.3%

Period ended 3 months ago

Filed May 8, 2026 · 2mo

2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+83.2%

SPY

+10.0%

Annualised alpha

+332.3%

Max drawdown

−12.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

5 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

67.4%

+0.2 pts

Top 5

100.0%

+0.2 pts

Top 10

100.0%

0.0 pts

HHI

5,241

Highly concentrated+322

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$119,668,108	5

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
NBP	NovaBridge Biosciences	+1,848,954	2,262,933	$5,566,815
No positions match the current search.

Trimmed

Positions the filer reduced

2 positions

Ticker	Company	Δ Shares	Shares	Value
RVMD	Revolution Medicines, Inc.	−71,418	828,974	$80,617,721
COGT	Cogent Biosciences, Inc.	−48,598	51,402	$1,978,462
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
ORIC	Oric Pharmaceuticals, Inc.	2,459,551	$31,162,511
No positions match the current search.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
PTGX	Protagonist Therapeutics, Inc	189,823	$16,579,140
AVBP	ArriVent BioPharma, Inc.	644,788	$12,973,134
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

5 positions · $119,668,108 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
RVMD	Revolution Medicines, Inc. Healthcare	Reduced	828,974	-71,418	$80,617,721	+12.4%	67.37%
ORIC	Oric Pharmaceuticals, Inc. Healthcare	NEW	2,459,551	NEW	$31,162,511	NEW	26.04%
NBP	NovaBridge Biosciences Healthcare	Added	2,262,933	+1,848,954	$5,566,815	+237.9%	4.65%
COGT	Cogent Biosciences, Inc. Healthcare	Reduced	51,402	-48,598	$1,978,462	−44.3%	1.65%
KRRO	Korro Bio, Inc. Healthcare	Held	30,265	0	$342,599	+41.3%	0.29%